July 16, 2025Frontiers in MedicineOpen Access

Prevalence of non-alcoholic fatty liver disease among inflammatory bowel disease patients: a systematic review and meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

YZYuyang ZhaoChinese Academy of Medical Sciences & Peking Union Medical College JWJiangbin WangQuanzhou Normal University HSHe SunTianjin University of Science and Technology

Discussion

Member takes

Implication

Systematic review highlights a 34% prevalence of non-alcoholic fatty liver disease in inflammatory bowel disease patients, implying a need for targeted screening.

Key Points

The study shows a 34% prevalence of non-alcoholic fatty liver disease among individuals with inflammatory bowel disease.
A cohort of over 429,550 IBD patients was analyzed across 26 studies to determine this prevalence.
Key risk factors for NAFLD in IBD patients include prolonged illness, obesity, and metabolic syndrome characteristics.
Findings suggest that increased NAFLD prevalence correlates with disease severity and pharmacological interventions.

Cite This Study

Zhao et al. (2025) studied this question.

synapsesocial.com/papers/689a02c3e6551bb0af8ccb8b https://doi.org/10.3389/fmed.2025.1517462

View Full Paper

Ask AI

Bookmark

Implication

Systematic review highlights a 34% prevalence of non-alcoholic fatty liver disease in inflammatory bowel disease patients, implying a need for targeted screening.

Prevalence of non-alcoholic fatty liver disease among inflammatory bowel disease patients: a systematic review and meta-analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Prevalence of non-alcoholic fatty liver disease among inflammatory bowel disease patients: a systematic review and meta-analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider